The News Review:
- US scientists go abroad to find patients for cancer studies – The…
- Inflazyme Pharmaceuticals Announces Departure of Senior Management
- New Research Tools Suggest Cancer And ther Diseases Are Too Complex…
US scientists go abroad to find patients for cancer studies – The…
Boston Globe – Dec 29, 2007
8 million in 2005 according to BBK Worldwide a patient recruitment company in Newton. Also because trials are usually aimed at patients suffering a very specific form or stage of cancer and who meet strict eligibility requirements the vast majority of volunteers are rejected. In Boston where so much clinical research takes place and ads for volunteers line the inside of subway cars patients are more likely to volunteer Getz said but even here trials aren’t necessarily any easier to fill because there are so many researchers competing for the available cancer patients and patients can typically enroll in only one trial at a time. The shortage has forced researchers to look increasingly abroad where patients are more likely to sign up because experimental cancer treatments give them a chance to be treated at top medical centers and get more aggressive care. Trials with recruits from other countries fill 40 percent faster than those limited to patients in the United States according to BBK and trials carried out in developing nations cost less too since the investigators and support staff are not paid as much as their American counterparts. But the globalization of trials carries ethical risks. Poor less-educated people in developing nations are more vulnerable to manipulation.
Inflazyme Pharmaceuticals Announces Departure of Senior Management
newsblaze.com – Dec 28, 2007
Business Development and Dr. John Langlands Senior Director Clinical Research will be leaving the Company on January 1 2008 to pursue new opportunities. Their departure will further reduce the burn of the Company during its final stages of reconciling the best steps for enhanced shareholder value after the close of the Biolipox transaction on November 19 2007. The monthly burn going forward is expected to average approximately $150000. Total severance payments are expected to amount to approximately $900000. The two remaining employees at the Company are Mike Liggett C.
New Research Tools Suggest Cancer And ther Diseases Are Too Complex…
Medical News Today – Medical News Today (press release) – Dec 28, 2007
Liu MD a medical oncologist. The review was funded by the National Institutes of Health and the Department of Defense. About Lombardi Comprehensive Cancer Center The Lombardi Comprehensive Cancer Center part of Georgetown University Medical Center and Georgetown University Hospital seeks to improve the diagnosis treatment and prevention of cancer through innovative basic and clinical research patient care community education and outreach and the training of cancer specialists of the future. Lombardi is one of only 39 comprehensive cancer centers in the nation as designated by the National Cancer Institute and the only one in the Washington DC area. For more information go to.
